Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
26.09
+0.14 (0.54%)
At close: Mar 9, 2026, 4:00 PM EDT
25.56
-0.53 (-2.03%)
After-hours: Mar 9, 2026, 7:29 PM EDT
Centessa Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,811 | 2,208 | 777 | 293 | 1,012 | - | |
| Market Cap Growth | 72.57% | 184.18% | 165.01% | -71.03% | - | - | |
| Enterprise Value | 3,683 | 1,775 | 579 | -83 | 433 | - | |
| Last Close Price | 26.09 | 16.75 | 7.96 | 3.10 | 11.26 | - | |
| PS Ratio | 254.07 | - | 113.40 | - | - | - | |
| PB Ratio | 11.63 | 5.50 | 3.29 | 0.87 | 2.06 | - | |
| P/TBV Ratio | 12.64 | 5.50 | 3.29 | 0.87 | 2.06 | - | |
| EV/Sales Ratio | 245.54 | - | 84.53 | - | - | - | |
| Debt / Equity Ratio | 0.39 | 0.29 | 0.36 | 0.21 | 0.15 | 1.82 | |
| Net Debt / Equity Ratio | -0.42 | -0.91 | -0.73 | -0.96 | -1.06 | -0.52 | |
| Net Debt / EBITDA Ratio | 0.60 | 1.82 | 1.01 | 1.54 | 3.73 | 0.15 | |
| Net Debt / FCF Ratio | 0.71 | 2.56 | 1.07 | 1.61 | 3.81 | 0.15 | |
| Asset Turnover | 0.03 | - | 0.02 | - | - | - | |
| Quick Ratio | 10.25 | 9.10 | 7.51 | 10.97 | 24.84 | 1.18 | |
| Current Ratio | 10.57 | 9.25 | 8.00 | 11.42 | 25.52 | 1.30 | |
| Return on Equity (ROE) | -60.62% | -73.93% | -52.79% | -52.24% | -154.41% | - | |
| Return on Assets (ROA) | -25.26% | -26.82% | -26.61% | -24.48% | -27.16% | - | |
| Return on Capital Employed (ROCE) | -51.00% | -38.80% | -53.40% | -51.80% | -23.00% | -337.00% | |
| Earnings Yield | -6.37% | -10.67% | -19.44% | -73.73% | -37.73% | - | |
| FCF Yield | -4.75% | -6.43% | -20.65% | -68.77% | -13.47% | - | |
| Buyback Yield / Dilution | -25.82% | -19.02% | -2.97% | -24.26% | -401.11% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.